Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells
Authors:
- Ken-Ichi TanakaKTKen-Ichi Tanaka
- Naoko FujitaNFNaoko Fujita
- Youichirou HigashiYHYouichirou Higashi
- Norio OgawaNONorio Ogawa
- 1 September 2002
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 330 (2) , 147-150
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatumNeuroscience Letters, 2002
- Effects of immunophilin ligands on hydrogen peroxide‐induced apoptosis in C6 glioma cellsSynapse, 2001
- Immunophilin ligands as a novel treatment for neurological disordersTrends in Pharmacological Sciences, 2000
- A Novel Immunophilin Ligand: Distinct Branching Effects on Dopaminergic Neurons in Culture and Neurotrophic Actions after Oral Administration in an Animal Model of Parkinson's DiseaseNeurobiology of Disease, 1998
- Neural actions of immunophilin ligandsTrends in Pharmacological Sciences, 1998
- A Nonimmunosuppressant FKBP-12 Ligand Increases Nerve RegenerationExperimental Neurology, 1997
- Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal modelsProceedings of the National Academy of Sciences, 1997
- A Model of Protein Targeting Mediated by Immunophilins and Other Proteins That Bind to hsp90 via Tetratricopeptide Repeat DomainsJournal of Biological Chemistry, 1996
- High brain densities of the immunophilin FKBP colocalized with calcineurinNature, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991